About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Coronary-to-Pulmonary Artery Fistula and Concomitant Acute Coronary Syndrome: Two Cases
Selami Demirelli1, Muhammed Hakan Tas2, Ziya Simsek2, Hakan Duman1, Emrah Ipek1
From the Department of Cardiology, Erzurum  Training and Research Hospital1, Erzurum, Turkey; Department of Cardiology, Faculty of Medicine, Atatürk University2, Erzurum, Turkey.
Corresponding Author:
Dr. Selami Demirelli
Email: demirelli23@yahoo.com
Received: 7-JAN-2014 Accepted: 21-JAN-2014 Published Online: 10-FEB-2014
DOI: http://dx.doi.org/10.17659/01.2014.0014
Abstract
The coronary-to-pulmonary artery fistulas are usually discovered incidentally during routine cardiac catheterization after the development of atherosclerotic coronary artery disease. We report the incidental finding of two cases of coronary-to-pulmonary artery fistulas who presented with acute coronary syndrome.
Keywords : Fistula, Pulmonary Artery, Cardiac Catheterization, Coronary Artery Disease, Acute Coronary Syndrome.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Dec 04, 2024